Supplementary Figure S5 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort

Authors :: Kensei Yamaguchi
Angela Teng
Bob Zimmermann
Taro Semba
Takao Takase
Shiori Okumura
Takuya Suzuki
Satoshi Yuki
Nozomu Machida
Kan Yonemori
Takuya Hamakawa
Yasuyoshi Sato
Akihito Kawazoe
Yoshito Komatsu
Takashi Oshima
Satoru Iwasa
Motohiro Hirao
Kohei Shitara
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure S5 shows pharmacodynamic changes in biomarkers over time (A) and changes by best overall response (B) in all study 114 cohorts.

Tools